Related Experiment Video
Updated: Jun 10, 2026

08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors
Yuan Yuan1, Magdalena Leszczynska, Sophya Konstantinovsky
1Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, N-0310 Oslo, Norway.
Diagnostic Cytopathology
|August 24, 2010
Summary
Netrin-4 protein is overexpressed in breast carcinoma effusions, validating gene expression findings. Its frequent presence in Müllerian carcinoma effusions suggests a role in gynecological cancer metastasis, but it does not predict patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Gene-expression arrays previously indicated NTN4 gene overexpression in breast carcinoma effusions versus primary tumors.
- Netrin-4 (NTN4) is a secreted protein involved in cell adhesion and migration.
- The role of Netrin-4 in carcinoma effusions and its clinical significance remain largely uncharacterized.
Purpose of the Study:
- To validate the overexpression of Netrin-4 protein in breast carcinoma effusions.
- To investigate the clinical relevance of Netrin-4 expression in breast carcinoma effusions.
- To explore Netrin-4 expression and its clinical relevance in Müllerian (ovarian, peritoneal, tubal) carcinoma effusions.
Main Methods:
- Immunohistochemistry was used to detect Netrin-4 protein expression in tissue sections.
- Samples included 82 breast carcinomas (53 effusions, 29 solid tumors) and 57 Müllerian carcinoma effusions.
- Carcinoma cell immunoreactivity for Netrin-4 was scored and correlated with clinicopathologic parameters and survival.
Main Results:
- Netrin-4 protein was significantly upregulated in breast carcinoma effusions (57%) compared to solid tumors (10%) (P < 0.001).
- Netrin-4 was expressed in 54% of Müllerian carcinoma effusions.
- No significant association was found between Netrin-4 expression and clinicopathologic parameters or survival in either breast or Müllerian carcinoma effusions.
Conclusions:
- The study validates the increased expression of Netrin-4 protein in breast carcinoma effusions.
- Frequent Netrin-4 expression in Müllerian carcinoma effusions suggests a potential role in gynecological cancer metastasis.
- Netrin-4 expression in effusions is not a reliable predictor of disease outcome.
